Puma pharmaceuticals new arrivals
Puma pharmaceuticals new arrivals
Puma pharmaceuticals new arrivals
Puma pharmaceuticals new arrivals
Puma pharmaceuticals new arrivals
Puma pharmaceuticals new arrivals

Puma pharmaceuticals new arrivals

Puma pharmaceuticals new arrivals, Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib an Investigational Aurora Kinase A Inhibitor Business Wire new arrivals

$39.00

SKU: 757595

Colour
  • Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib an Investigational Aurora Kinase A Inhibitor Business Wire
  • Puma Biotechnology Biotechnology The Pharmaletter The Pharmaletter
  • Puma Biotechnology Inc
  • Puma Biotechnology Announces Initiation of ALISCA Breast1 Phase II Trial of Alisertib in Hormone Receptor Positive HER2 Negative Metastatic Breast Cancer Business Wire
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus